Nouvelle déclaration d'incident
No de la demande: 2018-1592
Numéro de référence du titulaire d'homologation: SC2079017
Nom du titulaire (nom légal complet, aucune abbréviation): Dow AgroSciences Canada Inc.
Adresse: 2400, 215-2nd Street SW
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2P 1M4
Incident chez l'humain
Pays: CANADA
État: SASKATCHEWAN
Inconnu
ARLA No d'homologation 14879 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Lorsban 4E (Canada)
Oui
Inconnu
Site: Agricultural-Outdoor/Agricole-extérieur
Specify Type: Unknown
Inconnu
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Non
Inconnu
Non professionnel
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Dérive du pesticide à partir de la zone traitée
Inconnu
Respiratoire
>3 days <=1 wk / >3 jours <=1 sem
>30 min <=2 hrs / >30 min <=2 h
Caller's wife was allegedly exposed to the product on 7/19/2017 when a crop duster plane was going overhead dripping product on the ground. She was outside for approx. one minute and could smell the product. Two hours later she developed chest tightness, difficulty breathing, worsening of an existing headache, throat irritation, neck pain, and body aches. She took Advil for her symptoms, but it did not help and symptoms persisted. On7/26/2017 caller's wife was seen by her primary doctor. An unspecified blood test was performed which did not reveal anything abnormal. No further tests or treatments were performed. Caller states that the treating doctor did not seem overly concerned with the potential exposure or with the patients symptoms. His wife has had somewhat of an intermediate cough, but it is improving. He notes that she was working in their garden earlier today and seems to be feeling better. The patient does not have any further medical follow-up appointments scheduled.
Mineure
Direct exposure to this herbicide is not evident in this incident. The delayed onset of the patient symptoms hours after application is not suggestive of toxicity nor would they be expected symptoms should contact to airborne spray have occurred. Usually complications such as immediate onset of acute eye, skin and respiratory irritation may be seen following exposure to spray drift but these symptoms were not reported in this incident. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.